AzTrials
AzTrials

Edentulous JawNCT07177521

Primary Stability and Peri-implant Outcomes of Short Implants in Post-extraction Single-tooth Sites

A study testing Insertion of implants in post-extraction tooth in people with Edentulous Jaw and Tooth Loss, run by University of Bari Aldo Moro at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The placement of short implants in post-extraction sockets is a valuable option when residual bone height is limited, minimizing morbidity and treatment time. The management of the peri-implant gap and soft tissues may influence primary stability, hard/soft tissue remodeling, and implant success. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Edentulous Jaw, Tooth Loss, Toothless Mouth
What is being tested?
Insertion of implants in post-extraction tooth
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteItaly
Study dates
10 Jan 2025to 10 Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age ≥18 years.
  • Single-tooth post-extraction sites requiring immediate implant placement in posterior regions (premolars/molars) or selected anterior sites.
  • Planned short implant (≤7-8 mm length, 3.5-5.0 mm diameter).
  • Adequate oral hygiene, no active periodontal disease.
  • Written informed consent.

Who cannot join

  • Heavy smoking (>20 cigarettes/day).
  • Uncontrolled diabetes or systemic conditions affecting bone healing.
  • Current bisphosphonate/antiresorptive therapy.
  • Immunosuppression, pregnancy.
  • Poor oral hygiene or acute infection at site.
  • Severe bone dehiscence preventing primary stability.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Giuseppe D'Albis, Dr contact

+393495103642

giuseppe.dalbis@uniba.it

Saverio Capodiferro contact

saverio.capodiferro@uniba.it

Italy1 site, 1 recruiting
  • University of Bari Aldo Moro

    Bari, 70021

    Giuseppe D'Albis, +393495103642, dalbisgiuseppe@hotmail.com

    Recruiting

Other trials in Italy

About this study

Official title: Primary Stability and Peri-implant Outcomes of Short Implants in Post-extraction Single-tooth Sites: a Randomized Controlled Trial.

The placement of short implants in post-extraction sockets is a valuable option when residual bone height is limited, minimizing morbidity and treatment time. The management of the peri-implant gap and soft tissues may influence primary stability, hard/soft tissue remodeling, and implant success.

Being tested
Insertion of implants in post-extraction tooth
Medical subject headings
Jaw, Edentulous, Tooth Loss, Mouth, Edentulous

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Insertion of implants in post-extraction toothProcedure or surgery

    Two widely used approaches include:

    1. Socket grafting with a fully resorbable synthetic biomaterial (β-tricalcium phosphate + calcium sulfate).
    2. Socket grafting with a xenograft and a custom Sealing Socket Abutment (SSA) with a concave emergence profile.

    No randomized controlled trials have yet compared these protocols with integrated outcomes including resonance frequency analysis, peri-implant health indices, radiographic bone level changes, and digital intraoral scanning (IOS)-based morphometric analysis.

Study groups in NCT07177521
Study groupRoleWhat they receive
Group 1ExperimentalSocket grafting with a fully resorbable synthetic biomaterial (β-tricalcium phosphate + calcium sulfate).
Receives: Procedure: Insertion of implants in post-extraction tooth
Group 2Active comparatorSocket grafting with a xenograft and a custom Sealing Socket Abutment with a concave emergence profile.
Receives: Procedure: Insertion of implants in post-extraction tooth

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Primary stability

    To compare the primary stability (ISQ values at implant insertion) of short implants placed in post-extraction sockets using the two grafting protocols.

    Measured: 1 month

Secondary outcomes (2)
  1. Clinical Indices

    To assess peri-implant health indices (PD)

    Measured: 12 months

  2. Clinical Indices

    To assess peri-implant health indices (BoP)

    Measured: 12 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2025
  2. Study start10 Jan 2025
  3. Primary completion1 Jun 2026 (estimated)
  4. Study completion10 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07177521
Sponsor's protocol ID
Post-extraction-implants
Status last verified
Jan 2026
First submitted
8 Sep 2025
Last updated
27 Jan 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Insertion of implants in post-extraction tooth in people with Edentulous Jaw and Tooth Loss, run by University of Bari Aldo Moro at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Giuseppe D'Albis, Dr (+393495103642, giuseppe.dalbis@uniba.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Primary stability (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in